Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 107

Related Citations for PubMed (Select 24991542)

1.

Promoter region hypermethylation and mRNA expression of MGMT and p16 genes in tissue and blood samples of human premalignant oral lesions and oral squamous cell carcinoma.

Bhatia V, Goel MM, Makker A, Tewari S, Yadu A, Shilpi P, Kumar S, Agarwal SP, Goel SK.

Biomed Res Int. 2014;2014:248419. doi: 10.1155/2014/248419. Epub 2014 Jun 2.

2.

Promoter methylation of DAPK1, FHIT, MGMT, and CDKN2A genes in cervical carcinoma.

Banzai C, Nishino K, Quan J, Yoshihara K, Sekine M, Yahata T, Tanaka K; Gynecological Cancer Registry of Niigata.

Int J Clin Oncol. 2014 Feb;19(1):127-32. doi: 10.1007/s10147-013-0530-0. Epub 2013 Mar 14.

PMID:
23494221
3.

Aberrant promoter hypermethylation of p16 and MGMT genes in oral squamous cell carcinomas and the surrounding normal mucosa.

Kato K, Hara A, Kuno T, Mori H, Yamashita T, Toida M, Shibata T.

J Cancer Res Clin Oncol. 2006 Nov;132(11):735-43. Epub 2006 Jun 22.

PMID:
16791592
4.

Promoter hypermethylation of multiple genes in early gastric adenocarcinoma and precancerous lesions.

Zou XP, Zhang B, Zhang XQ, Chen M, Cao J, Liu WJ.

Hum Pathol. 2009 Nov;40(11):1534-42. doi: 10.1016/j.humpath.2009.01.029. Epub 2009 Aug 19.

PMID:
19695681
5.
6.
7.

p16(INK4A) promoter hypermethylation is associated with invasiveness and prognosis of oral squamous cell carcinoma in an age-dependent manner.

Su PF, Huang WL, Wu HT, Wu CH, Liu TY, Kao SY.

Oral Oncol. 2010 Oct;46(10):734-9. doi: 10.1016/j.oraloncology.2010.07.002. Epub 2010 Aug 21.

PMID:
20729138
8.

Correlation of promoter hypermethylation in hTERT, DAPK and MGMT genes with cervical oncogenesis progression.

Iliopoulos D, Oikonomou P, Messinis I, Tsezou A.

Oncol Rep. 2009 Jul;22(1):199-204.

PMID:
19513524
9.

Recurrence in oral and pharyngeal cancer is associated with quantitative MGMT promoter methylation.

Taioli E, Ragin C, Wang XH, Chen J, Langevin SM, Brown AR, Gollin SM, Garte S, Sobol RW.

BMC Cancer. 2009 Oct 6;9:354. doi: 10.1186/1471-2407-9-354.

10.

Promoter hypermethylation and expression profile of MGMT and CDH1 genes in oral cavity cancer.

Kordi-Tamandani DM, Moazeni-Roodi AK, Rigi-Ladiz MA, Hashemi M, Birjandian E, Torkamanzehi A.

Arch Oral Biol. 2010 Oct;55(10):809-14. doi: 10.1016/j.archoralbio.2010.06.017. Epub 2010 Aug 1.

PMID:
20674887
11.

DNA methylation profiling revealed promoter hypermethylation-induced silencing of p16, DDAH2 and DUSP1 in primary oral squamous cell carcinoma.

Khor GH, Froemming GR, Zain RB, Abraham MT, Omar E, Tan SK, Tan AC, Vincent-Chong VK, Thong KL.

Int J Med Sci. 2013 Oct 12;10(12):1727-39. doi: 10.7150/ijms.6884. eCollection 2013.

12.

Promoter methylation status of hMLH1, MGMT, and CDKN2A/p16 in colorectal adenomas.

Psofaki V, Kalogera C, Tzambouras N, Stephanou D, Tsianos E, Seferiadis K, Kolios G.

World J Gastroenterol. 2010 Jul 28;16(28):3553-60.

13.

Comethylation of p16 and MGMT genes in colorectal carcinoma: correlation with clinicopathological features and prognostic value.

Krtolica K, Krajnovic M, Usaj-Knezevic S, Babic D, Jovanovic D, Dimitrijevic B.

World J Gastroenterol. 2007 Feb 28;13(8):1187-94.

14.

Involvement of TSC genes and differential expression of other members of the mTOR signaling pathway in oral squamous cell carcinoma.

Chakraborty S, Mohiyuddin SM, Gopinath KS, Kumar A.

BMC Cancer. 2008 Jun 6;8:163. doi: 10.1186/1471-2407-8-163.

15.

Promoter hypermethylation of RASSF1A, MGMT, and HIC-1 genes in benign and malignant colorectal tumors.

Abouzeid HE, Kassem AM, Abdel Wahab AH, El-mezayen HA, Sharad H, Abdel Rahman S.

Tumour Biol. 2011 Oct;32(5):845-52. doi: 10.1007/s13277-011-0156-7. Epub 2011 Jan 28. Erratum in: Tumour Biol. 2011 Oct;32(5):1055. Abouzeid, Hamdy E [added]; Kassem, Abdel Meguid [added].

PMID:
21274674
16.

Aberrant promoter hypermethylation of the CHFR gene in oral squamous cell carcinomas.

Baba S, Hara A, Kato K, Long NK, Hatano Y, Kimura M, Okano Y, Yamada Y, Shibata T.

Oncol Rep. 2009 Nov;22(5):1173-9.

PMID:
19787237
17.

The A/G allele of rs16906252 predicts for MGMT methylation and is selectively silenced in premalignant lesions from smokers and in lung adenocarcinomas.

Leng S, Bernauer AM, Hong C, Do KC, Yingling CM, Flores KG, Tessema M, Tellez CS, Willink RP, Burki EA, Picchi MA, Stidley CA, Prados MD, Costello JF, Gilliland FD, Crowell RE, Belinsky SA.

Clin Cancer Res. 2011 Apr 1;17(7):2014-23. doi: 10.1158/1078-0432.CCR-10-3026. Epub 2011 Feb 25.

18.

Gene hypermethylation in tumor tissue of advanced oral squamous cell carcinoma patients.

Supić G, Kozomara R, Branković-Magić M, Jović N, Magić Z.

Oral Oncol. 2009 Dec;45(12):1051-7. doi: 10.1016/j.oraloncology.2009.07.007. Epub 2009 Aug 8.

PMID:
19665921
19.

MGMT expression in oral precancerous and cancerous lesions: correlation with progression, nodal metastasis and poor prognosis.

Sawhney M, Rohatgi N, Kaur J, Gupta SD, Deo SV, Shukla NK, Ralhan R.

Oral Oncol. 2007 May;43(5):515-22. Epub 2006 Sep 25.

PMID:
16996781
20.

Aberrant DNA methylation of P16, MGMT, and hMLH1 genes in combination with MTHFR C677T genetic polymorphism in esophageal squamous cell carcinoma.

Wang J, Sasco AJ, Fu C, Xue H, Guo G, Hua Z, Zhou Q, Jiang Q, Xu B.

Cancer Epidemiol Biomarkers Prev. 2008 Jan;17(1):118-25. doi: 10.1158/1055-9965.EPI-07-0733.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk